Here’s why there are fewer and fewer breakthrough drugs

Here’s why there are fewer and fewer breakthrough drugs

MIT Press Reader |
In the UK, the U.S., France, Germany, and elsewhere, we are seeing the first signs that, for complex reasons, life ...